Fig. 3From: Comparison of RNA-seq and microarray-based models for clinical endpoint predictionAnalysis of factors potentially affecting prediction performances of RNA-seq-based models. a Distribution of MCC values of all models for each endpoint according to RNA-seq data processing pipelines (MAV, Magic-AceView; TAV, TopHat-AceView; TUC, TopHat-UCSC). b Distribution of MCC values of all models for each endpoint according to feature levels, that is, gene, transcript (TS), and exon-junction (Jct) levelsBack to article page